Show results for
Refine by
Locations
- Europe
- Albania
- Andorra
- Austria
- Belarus
- Belgium
- Bosnia & Herzegovina
- Bulgaria
- Croatia
- Cyprus
- Czech Republic
- Denmark
- Estonia
- Faroe Islands
- Finland
- France
- Germany
- Greece
- Hungary
- Iceland
- Ireland
- Italy
- Kosovo
- Latvia
- Liechtenstein
- Lithuania
- Luxembourg
- Macedonia
- Malta
- Moldova
- Monaco
- Montenegro
- Netherlands
- Northern Ireland
- Norway
- Poland
- Portugal
- Romania
- San Marino
- Serbia
- Slovakia
- Slovenia
- Spain
- Sweden
- Switzerland
- Turkey
- Ukraine
- United Kingdom
- Vatican City
Applications
- Clinical Immunology and Intensive Care Medicine for Haemophilia
- Clinical Immunology and Intensive Care Medicine for Immunoglobulins
- Clinical Immunology and Intensive Care Medicine for Antibody Deficiency
- Solutions for Endometriosis
- Solutions for Severe but Non-Specific Symptoms
- Microbiotica Solutions for Clinical Data and Sample Sets
Disease Progression Equipment Supplied In Europe
58 equipment items found
Manufactured by:BioArctic AB based inStockholm, SWEDEN
The antibody PD1601 is targeting alpha-synuclein for treatment of Parkinson’s disease. The aim is to develop a disease modifying treatment that stops or slows down disease progression. The project is conducted in collaboration with ...
Manufactured by:BioArctic AB based inStockholm, SWEDEN
The antibody PD1602 is targeting alpha-synuclein for treatment of Parkinson’s disease. The aim is to develop a disease modifying treatment that stops or slows down disease progression. The project is conducted in collaboration with ...
Manufactured by:BioArctic AB based inStockholm, SWEDEN
At BioArctic, research is in progress to develop new antibodies for the treatment of Alzheimer’s disease aimed at slowing down or stopping disease progression by addressing novel ...
Manufactured by:BioArctic AB based inStockholm, SWEDEN
The drug candidate ABBV-0805 is a monoclonal antibody that selectively binds and eliminates oligomers and protofibrils of alpha-synuclein. The goal is to develop a disease modifying treatment that stops or slows down disease ...
by:Pureims B.V. based inRoden, NETHERLANDS
Levodopa Cyclops™ is a levodopa dry powder inhaler for the fast and reliable relief of OFF episodes in Parkinson’s disease. As such, Levodopa Cyclops™ answers a major unmet medical need. Levodopa is the cornerstone in the treatment of Parkinson’s disease for well over 50 years. It is the most effective, safe and well tolerated drug ...
Manufactured by:Aison Technologies based inSchlieren, SWITZERLAND
Surrogate parameter for rheumatoid arthritis diagnosis. Reduce need for expensive MRI scans. Disease progression monitoring in drug development and research. Save time, reduce costs and increase ...
by:Numares GROUP Corp based inRegensburg, GERMANY
Common cancers with established benefit of early diagnosis but for which there are no sensitive or specific tests are prostate, bladder and liver cancer1. Expensive imaging procedures are routinely required in clinical practice for diagnosis or to monitor disease progression of these cancers. To date, there are no accurate biomarkers for either diagnosis or ...
Manufactured by:Quanterix Corporation based inBillerica, MASSACHUSETTS (USA)
Unleashing the power of next-generation Simoa® Planar Array technology for robust multiplex circulating biomarker detection at the earliest stages of disease progression - even at healthy baseline levels. The Quanterix SP-X Imaging and Analysis System is a complete benchtop system that offers true multiplex detection at both acute and baseline levels. For the ...
Manufactured by:Microbiotica Limited based inLittle Chesterford, UNITED KINGDOM
Microbiotica accesses high quality large-scale clinical datasets in order to identify microbiome-based biomarkers of drug response, drug side-effects or disease progression. The company has accessed the clinical data from academic/clinical collaborations (University of Adelaide, Cambridge University Hospitals/Cancer Research UK) or from pharma partners ...
Manufactured by:Ncardia Services B.V. based inLeiden, NETHERLANDS
Astrocytes are essential players in neurodegenerative disease progression providing a valuable tool for drug discovery and disease modeling. Human iPSC-derived astrocytes generated with our standardized process express key identity markers and support co-culture with human iPSC-derived neurons. Our team can manufacture astrocytes at scale ...
by:tiakis BIOTECH AG based inKiel, GERMANY
Tiprelestat is a pioneering anti-inflammatory and tissue protective drug being developed for the treatment of pulmonary-arterial hypertension, the prevention of serious disease progression of COVID-19 and the prevention of postoperative inflammatory ...
Manufactured by:betaSENSE based in, GERMANY
The advancement of the iRS technology from betaSENSE represents a significant innovation in the field of Parkinson's disease diagnostics. This technology addresses the critical unmet medical needs in accurately diagnosing Parkinson's and distinguishing between idiopathic and atypical cases. While there have been notable improvements in Parkinson's treatment, existing therapies ...
Manufactured by:Datar Cancer Genetics based inGuildford, UNITED KINGDOM
CTACs include cancer cells that escape from the tumor and enter the bloodstream (circulating tumor cells, CTCs) as well as tumor-associated cells (TACs) which contribute to tumor survival and growth. Chemo-resistance in CTACs may be associated with a risk of treatment failure and disease ...
Manufactured by:GENFIT based inLoos, FRANCE
Nonalcoholic steatohepatitis (NASH) remains largely underdiagnosed, as it carries no obvious symptoms in its early stages, and also because of the lack of widely available non-invasive tests specifically developed to diagnose the disease. The underdiagnosis of NASH represents a major unmet need, and is a barrier for identification of patients at higher risk for ...
Manufactured by:MR Solutions based inGuildford, UNITED KINGDOM
MRI’s unparalleled ability to noninvasively monitor biological variables in living subjects makes it invaluable in preclinical research, facilitating the serial tracking of disease progression or therapeutic interventions, thereby enhancing the validity and relevance of biological and translational ...
Manufactured by:Fab’entech based inLyon, FRANCE
These antibodies replace those that the patient has not had time to produce naturally. They recognise then neutralise the virus or toxin in only a few minutes, thereby stopping disease’s ...
Manufactured by:LimFlow, Inc. based inSan Jose, CALIFORNIA (USA)
Living with Peripheral Artery Disease (PAD) that progresses to CLTI is challenging. Life revolves around chronic leg pain that can become unbearable over time. The end stage of the disease is characterized by non-healing foot ulcers that considerably lessen mobility and quality of ...
Manufactured by:Toleris Biotherapeutics GmbH based inWürzburg, GERMANY
By leveraging optimized soluble versions of the non-classical MHC Ib molecule HLA-G, AIM Biologicals can accumulate in lymph nodes to induce regulatory CD8+ T cells that protect tissues presenting autoantigens attacked in autoimmune diseases. This targeted approach contrasts with traditional immunosuppressants that broadly inhibit immune functions, risking opportunistic ...
by:Gain Therapeutics, Inc. based inBethesda, MARYLAND (USA)
Morquio B, also known as Mucopolysaccharidosis type IV (MPS IV), is a progressive disease mostly impacting the skeleton, caused by mutations in GLB1, the gene that encodes the beta-galactosidase (GLB) enzyme. These mutations result in the misfolding and subsequent dysfunction of GLB, which leads to the toxic substrate accumulation of keratan sulfate in organs and ...
by:Gain Therapeutics, Inc. based inBethesda, MARYLAND (USA)
GM1 Gangliosidosis is a hereditary, progressive disease mostly impacting neurons in the brain and spinal cord, caused by mutations in GLB1, the gene that encodes the beta-galactosidase (GLB) enzyme. These mutations result in the misfolding and subsequent dysfunction of GLB, which leads to the toxic substrate accumulation of GM1 ganglioside in organs and tissues. ...